Navigation Links
Sequenom Introduces iPLEX® ADME PGx Panel on MassARRAY® System
Date:10/4/2011

panels, reliance upon the collaborative efforts of other parties, ongoing litigation involving the Company, the Company's financial position, the Company's ability to manage its existing cash resources or raise additional cash resources, competition, intellectual property protection and intellectual property rights of others, government regulation particularly with respect to diagnostic products and laboratory developed tests, obtaining or maintaining regulatory approvals, and other risks detailed from time to time in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 and other documents subsequently filed with or furnished to the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
2. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
3. SEQUENOM Announces Launch of MassARRAY Compact 96 System
4. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
5. Sequenom Appoints Two New Board Members
6. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
7. Sequenom to Present at Two Financial Conferences in March
8. Sequenom to Present at Two Financial Conferences in September
9. Sequenom Announces Formation of Ophthalmology Clinical Advisory Board
10. Sequenom Announces Exercise in Full of Underwriters Option to Purchase Additional Shares
11. Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ... collagenase-based products marketed as XIAFLEX ® (collagenase ... XIAPEX ® in the EU, today announced ... Phase 2a study of CCH for the potential ... results showed that all three doses of CCH ...
(Date:8/21/2014)... DUBLIN, Ireland , August 21, 2014 ... and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone ) has announced the ... Market 2014-2018"  report to their offering.  ... also known as hormone therapy, is a ... longer being produced by the body. This ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014 Mathematic ... at Harvard University , and funded by the ... aggressive cells within tumors can be visually identified for elimination. ... tumor,s growth. The study, which shows a topological map of ... needed time in cancer research, for while tumor cells can ...
(Date:8/21/2014)... Ontotext S4 , The Self ... . Now the same enterprise hardened text mining, ... unstructured data is available to start-ups and mid-size businesses ... Organizations that do not have resources to evaluate and ... S4 since there is no need for on premise ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4
... , , , , , Other important parameters for optimizing electroporation., , , ... Field strength , , Pulse length ... field pulses , Adjustment , ... of DNA/RNA , Influence , of ...
... , , , , , , , Table A , , ... , , <TD , ... <TD align=middle , ... colSpan=2> Heat of Vaporization , <TD align=middle ...
... , , , , , Contents , , , ... 1 , Measuring station and accessories ... 2 , Testing conditions and pipetting conditions , ... Calibrating pipettes and bottletop dispensers , / mode of ...
Cached Biology Technology:Optimizing electroporation parameters 2Optimizing Bchi Rotary Evaporator Applications 2Optimizing Bchi Rotary Evaporator Applications 3Optimizing Bchi Rotary Evaporator Applications 4Optimizing Bchi Rotary Evaporator Applications 5Optimizing Bchi Rotary Evaporator Applications 6Optimizing Bchi Rotary Evaporator Applications 7Optimizing Bchi Rotary Evaporator Applications 8Optimizing Bchi Rotary Evaporator Applications 9Optimizing Bchi Rotary Evaporator Applications 10Optimizing Bchi Rotary Evaporator Applications 11Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 2Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 3Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 4Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 5Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 6Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 7Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 8Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 9Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 10Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 11Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 12Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 13Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 14Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 15Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 16Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 17Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 18Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 19Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 20Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 21Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 22Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 23Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 24Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 25
(Date:8/22/2014)... the birds and the bees. But that old ... fertilized. The fertilization process for flowering plants is ... male and female reproductive cells. New research from ... Munich, and including Carnegie,s Wolf Frommer, David Ehrhardt, ... signaling process that guides flowering plant fertilization. It ...
(Date:8/21/2014)... -- Nxt-ID, Inc. (OTCQB: NXTD), a biometric authentication company ... that its shares of common stock and the warrants ... proposed underwritten public offering of common stock and warrants ... Market, subject to closing of its proposed underwritten public ... trade under the symbol "NXTD" and "NXTDW," respectively. ...
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- LiveScan Service ... agreed to a partnership with Gabriel Health Institute, ... fastest growing Certified Nursing Assistant preparatory schools. ...  an exclusive member of Binary,s LiveScan service provider,s ... will improve its service capabilities by widening ...
Breaking Biology News(10 mins):Calcium and reproduction go together 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3
... Reducing Emissions from Deforestation and Forest Degradation ... that aims to financially compensate landowners and stewards ... as promoting forest conservation, sustainable forest management and ... and implemented correctly, REDD+ has the potential to ...
... new signaling pathway, which is important for the regulation ... an international team of scientists led by prof Ivan ... studied the involvement of ubiquitin, a universally present signaling ... scientific journal " Nature " the scientists report a ...
... the first ever European-wide retrospective analysis presented today at ... trientine continue to be effective treatments, providing positive survival ... liver transplant. , Wilson disease is a rare genetic ... the body effectively, leading to excess copper build up, ...
Cached Biology News:REDD+, Technical, Socioeconomic and Political Dimensions 2REDD+, Technical, Socioeconomic and Political Dimensions 3A new signaling pathway of the immune system is elucidated 2European-wide study confirms benefits of D-penicillamine and trientine for Wilson disease 2
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
NATIVE RAT OSTEOCALCIN...
... Specifications(L x W x H): 17 ... 5/16"18.7 lbsCapacity: 12 slidesTime: Programmable 0 - ... denaturation and hybridization steps 40 user programmable ... and Fixed temperature) Rapid temperature ramp-up from ...
Defender against cell death 1...
Biology Products: